Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. The sudden price rise can be attributed to growing investor optimism related to increased sales of the company's portfolio of products that are marketed targeting oncology, immunology, neuroscience and infectious disease. This company is expected to post quarterly loss o ...